1. COVID-19 like illness, not confirmed by RAT/ RTPCR. <br/ >2. Prior treatment with any of Jakinibs for any <br/ >indication. <br/ >3. Past treatment with any of the following biologics - <br/ >TNF(i), tocilizumab(in the last 3 months). <br/ >4. e-GFR < 30 ml/hr at screening. <br/ >5. Pre-existing lung disease requiring home oxygen <br/ >therapy. <br/ >6. Malignancies on conventional chemotherapeutic <br/ >regimens or targeted treatments. <br/ >7. Post- transplant with ongoing immunosuppressive <br/ >therapy, <br/ >8. HIV/AIDS <br/ >9. Pregnancy <br/ >10. Critically ill patients in ICU <br/ >11. Coexisting septic shock, and/or multiple organ <br/ >dysfunction <br/ >12. Anticipated death within next 24 hours as per

1. COVID-19 like illness, not confirmed by RAT/ RTPCR. <br/ >2. Prior treatment with any of Jakinibs for any <br/ >indication. <br/ >3. Past treatment with any of the following biologics - <br/ >TNF(i), tocilizumab(in the last 3 months). <br/ >4. e-GFR < 30 ml/hr at screening. <br/ >5. Pre-existing lung disease requiring home oxygen <br/ >therapy. <br/ >6. Malignancies on conventional chemotherapeutic <br/ >regimens or targeted treatments. <br/ >7. Post- transplant with ongoing immunosuppressive <br/ >therapy, <br/ >8. HIV/AIDS <br/ >9. Pregnancy <br/ >10. Critically ill patients in ICU <br/ >11. Coexisting septic shock, and/or multiple organ <br/ >dysfunction <br/ >12. Anticipated death within next 24 hours as per

N/A

N/A

1. COVID-19 like illness, not confirmed by RAT/ RTPCR. <br/ >2. Prior treatment with any of Jakinibs for any <br/ >indication. <br/ >3. Past treatment with any of the following biologics - <br/ >TNF(i), tocilizumab(in the last 3 months). <br/ >4. e-GFR < 30 ml/hr at screening. <br/ >5. Pre-existing lung disease requiring home oxygen <br/ >therapy. <br/ >6. Malignancies on conventional chemotherapeutic <br/ >regimens or targeted treatments. <br/ >7. Post- transplant with ongoing immunosuppressive <br/ >therapy, <br/ >8. HIV/AIDS <br/ >9. Pregnancy <br/ >10. Critically ill patients in ICU <br/ >11. Coexisting septic shock, and/or multiple organ <br/ >dysfunction <br/ >12. Anticipated death within next 24 hours as per

1. COVID-19 like illness, not confirmed by RAT/ RTPCR. <br/ >2. Prior treatment with any of Jakinibs for any <br/ >indication. <br/ >3. Past treatment with any of the following biologics - <br/ >TNF(i), tocilizumab(in the last 3 months). <br/ >4. e-GFR < 30 ml/hr at screening. <br/ >5. Pre-existing lung disease requiring home oxygen <br/ >therapy. <br/ >6. Malignancies on conventional chemotherapeutic <br/ >regimens or targeted treatments. <br/ >7. Post- transplant with ongoing immunosuppressive <br/ >therapy, <br/ >8. HIV/AIDS <br/ >9. Pregnancy <br/ >10. Critically ill patients in ICU <br/ >11. Coexisting septic shock, and/or multiple organ <br/ >dysfunction <br/ >12. Anticipated death within next 24 hours as per